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In a recent paper, Acemoglu and Johnson (2007) argue that the large increases in population 
health witnessed in the 20
th century may have lowered income levels. We argue that this result 
depends crucially on their assumption that initial health and income do not affect subsequent 
economic growth.   Using their data we reject this assumption in favor of a model of conditional 
convergence, with income adjusting to its steady state over time. We show that, allowing for 
conditional convergence, exogenous improvements in health due to technical advances 
associated with the epidemiological transition appear to have increased income levels.  
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 1. Introduction 
 
In a recent paper, Acemoglu and Johnson (2007) present results indicating that increases in 
population health, as measured by higher life expectancy, are negatively correlated with 
economic growth in cross-country panel data. This appears to contradict much of the preceding 
literature, surveyed in Weil (2007) and Bloom, Canning, and Sevilla (2004), which generally 
finds that countries with better health achieve higher rates of economic growth. 
 
Acemoglu and Johnson express three concerns about the findings of previous studies linking 
population health to the growth of income per capita. The first concern involves the possibility 
that the estimated positive coefficient of health in an empirical growth equation is biased upward 
by the omission of some variable that is positively associated with both good health and high 
income growth. As the authors argue, countries with low life expectancy may be disadvantaged 
in other ways, so that the negative effects of other country-specific factors might be falsely 
attributed to ill health. The second concern focuses on reverse causality from economic growth 
to population health, since health depends on health inputs that are more affordable in richer 
countries. The third issue is a general equilibrium effect of health on economic growth via lower 
mortality and larger population numbers, an effect that will not be captured by individual-level 
studies.  
 
Given these concerns, Acemoglu and Johnson argue that the appropriate way to identify the total 
effect of health on economic growth is empirical work at the aggregate level with valid 
instrumentation to address the critical endogeneity issue. The instrument they propose depends 
on exogenous shocks to national health generated by improvements in health technology. 
Technological innovations in prevention and treatment occur for different diseases at different 
times.
2 They also affect health differently in each country since the prevalence of each disease 
varies across countries.   
 
                                                 
2 We follow Acemoglu and Johnson in regarding disease specific technological advances as exogenous. However a 
case could be made that research has focused on the diseases of rich countries, rather than poor countries, making 
technological advances endogenous. 
 
 
2The issues raised by Acemoglu and Johnson are indisputably central to understanding the health-
income links. However, we argue that the discrepancy between the Acemoglu and Johnson 
results and those reported in earlier literature is not a consequence of addressing these three 
issues via a new instrument, but rather of the way in which the dynamic relationship between 
health and income is modeled and estimated.  Acemoglu and Johnson specify a formulation in 
which current income is a function of, and adjusts instantaneously to, current health.  
 
There are both theoretical and empirical reasons to expect income to adjust non-instantaneously 
to changes in population health. The standard partial adjustment model that lies behind the 
conditional convergence framework for modeling economic growth assumes that income 
converges slowly its steady-state level; a convergence rate of about 2% per year is a common 
estimate (Barro and Sala-i-Martin 2004; Durlauf, Johnson et al. 2005).  It is likely that, when 
health improves, income adjusts slowly to the new steady state. There is growing evidence that 
physical and cognitive development are closely linked to health and nutrition in utero and during 
the first few years of life. Health human capital may consequently be affected by conditions in 
the early years of childhood, while the returns to this capital are realized mainly during a 
person’s adult life (Heckman 2007). For example, Barker (1992) and Crimmins and Finch (2006) 
find that early childhood infections have large effects on adult health. Behrman and Rosenzweig 
(2004) find that development in utero, as measured by birth weight, has long-term economic 
effects on adult productivity and earnings. Bleakley (2003; 2006) and Kremer and Miguel (2004) 
find that early childhood exposure to disease has effects on educational outcomes while 
(Hoddinott, Maluccio et al. 2008) find that early childhood nutrition has substantial effects on 
adult income. Case, Fertig, and Paxson (2005) and Schultz (2005) provide further evidence of a 
link between health in childhood and later economic success.  
 
This empirical evidence suggests that health has a positive effect on income in the long term.  
We are then left with the question why Acemoglu and Johnson find such a strong negative effect 
of health improvements on growth in per capita income. As we show in the following section, 
the negative correlation between changes in income and changes in life expectancy found by 
Acemoglu and Johnson has little to do with instrumentation or the relatively small sample of 47 
countries chosen by the authors.  The reason this negative correlation emerges is simply that 
 
 
3countries with good health in 1940 were the ones that benefited least from subsequent global 
health technology improvements, but are also the countries whose economies have grown fastest 
since 1940. Acemoglu and Johnson ignore the effect of initial conditions on economic growth 
and limit their attention to the unconditional negative correlation between health gains and 
economic growth. Since there is strong convergence in health, countries with relatively good 
initial health conditions have relatively smaller subsequent health gains  (Cutler, Deaton et al. 
2006). The unconditional regression of changes in income on changes in life expectancy omits 
initial conditions as one of the fundamental drivers of subsequent economic growth. Since the 
correlation between initial health conditions and subsequent changes in health is strongly 
negative, the resulting estimates display a negative bias. The magnitude of the omitted variable 
bias is large; once we control for initial conditions, the estimated effect of changes in life 
expectancy on economic growth changes sign and becomes positive, with large and highly 
significant coefficients both on initial levels of, and changes in life expectancy. 
 
If the instrumental variable approach chosen by Acemoglu and Johnson were valid, this omitted 
variable (or selection) bias would be irrelevant.  A good instrument essentially mimics a random 
assignment of health improvements, and thereby allows researchers to identify the causal effect 
of health on income, independent of other omitted variables.  Improvements in health technology 
during the last century could be regarded as random shocks, and we could regard these 
innovations as plausible instruments.  Major advances in our understanding of infectious diseases 
and the emergence of cheap and effective prevention and treatment interventions have indeed led 
to rapid health improvements. Since the initial burden of disease varies across countries, these 
health improvements provide differential positive shocks to all countries. Acemoglu and Johnson 
discuss innovations developed for 15 prominent diseases in the early 20
th century, ranging from 
measles to tuberculosis to malaria
3. They take “predicted mortality” to be the actual mortality 
rate from these diseases in 1940, but once the cure for a specific disease is accessible to a 
country, the predicted mortality from that disease is taken to be zero. The assumption that the 
burden of malaria drops to zero after the intervention of DDT might appear odd from a historical 
                                                 
3 The 15 diseases are tuberculosis, malaria, pneumonia, influenza, cholera, typhoid, smallpox, whooping cough, 
measles, diphtheria, scarlet fever, yellow fever, plague, typhus fever, and dysentery/diarrhea-related diseases.  
 
 
4perspective. It makes sense from an econometric perspective, however, as it avoids confounding 
the exogenous health shock with endogenous domestic demand and implementation factors.  
 
The problem with the instrument constructed by Acemoglu and Johnson is that it assumes the 
predicted mortality to be exogenous and not affected by contemporaneous income shocks. This 
implies that the initial mortality rate in 1940 due to each disease must be unaffected by income 
levels in 1940. We think this is implausible, particularly given that the problem being addressed 
is endogeneity of life expectancy, which is closely linked to mortality. We discuss this issue in 
detail in the following for the case of malaria, arguing that malaria mortality in 1940 was 
endogenous, with richer countries in 1940 being better able to afford vector control of 
mosquitoes, such as swamp clearance.     
 
To put it in the context of the evaluation literature, the “natural experiment” constructed by 
Acemoglu and Johnson is flawed because the “treatment group” that received large health gains 
from technological innovations is fundamentally different from the “control group” that received 
low health gains. The treatment group, which benefits most from technological advances, had 
poor health initially (low life expectancy) while the control group had good health (high life 
expectancy).  If initial health matters for subsequent economic growth, this difference between 
the treatment and control groups will bias their result.  
 
In our empirical analysis we focus on economic growth over the period 1940-2000. We expand 
on the Acemoglu and Johnson model by allowing initial health and income to affect subsequent 
economic growth. This can be regarded as adding what may be omitted variables to the model. 
We also show formally that adding these explanatory variables makes the identifying assumption 
in the model that disease specific mortality rates 1940 are uncorrelated with the income shock in 
2000. This seems to us more plausible than the Acemoglu and Johnson assumption than that 
1940 mortality is uncorrelated with the income shock in 1940
4.  By controlling for initial health 
and income we remove the correlation between the instrument and these previously omitted 
variables. In this alternative framework, we show that improvements in life expectancy over the 
                                                 
4 We test, and cannot reject, that the income shocks in 1940 and 2000 are uncorrelated. 
 
 
5period 1940-2000, instrumented with the change in predicted mortality due to technological 
innovations, have a positive effect on the growth of income per capita.      
 
To provide a clearer understanding of the results generated by Acemoglu and Johnson, we first 
analyze the relationship between health, economic growth and predicted mortality in the data set 
constructed by Acemoglu and Johnson in Section 2 of this paper. We show that there is a strong 
positive correlation between initial health and subsequent economic growth. Since there is a 
pronounced negative correlation between initial health and subsequent improvements in health, a 
negative correlation between improvements in health and economic growth emerges. These 
correlations are consistent with the view that good initial health leads to rapid subsequent 
economic growth. They are, however, also consistent with the view that the correlation of 
changes in income and health is negative.  
 
In Section 3, we show formally that in the model used by Acemoglu and Johnson the identifying 
assumption is that current income shocks do not affect current disease-specific mortality rates. 
We also construct an alternative expanded model, in which the predicted mortality instrument 
used by Acemoglu and Johnson is valid provided only that future income shocks do not affect 
current disease-specific mortality. In Section 4 we report parameter estimates based on the two 
models and show that while the Acemoglu and Johnson model finds a negative effect of health 
improvements on economic growth, our model finds relatively large and highly significant 
positive effects of health on income. 
 
2. Patterns of Health and Economic Growth 
 
We begin by examining the 47 data points used in Acemoglu and Johnson’s main regressions. 
The data were provided by the authors and are as described in the original paper (Acemoglu and 
Johnson 2007). Figure 1 shows the relationship between life expectancy in 1940 and growth in 
income per capita over the period 1940-2000. The figure reveals a positive relationship:  
countries with high life expectancy in 1940 had more rapid per capita income growth over the 
period 1940-2000. Figure 2 shows the relationship between life expectancy in 1940 and the 
growth rate of life expectancy during 1940-2000. Figure 2 shows that initial life expectancy 
 
 
6almost perfectly predicts subsequent percentage gains in life expectancy, with countries with low 
initial life expectancy having the largest subsequent gains in life expectancy.  This relationship 
reflects a diffusion of health technologies that have allowed rapid health improvements even in 
poor countries and overall convergence in life expectancy (Cutler, Deaton et al. 2006), though 
there is evidence that not all countries are converging to the same steady state (Bloom and 
Canning, 2008).  
 
Figure 3 shows a negative relationship between growth in life expectancy over the period 1940-
2000, and the growth rate of income per capita over the same period
5. Figure 3 is a visual 
representation of the Acemoglu and Johnson ordinary least squares estimates of the effect of 
improvements in life expectancy on economic growth; the countries with above average gains in 
life expectancy also have below average growth in income per capita over the period. These 
patterns in the data are not due to the selection of particular countries or a particular time period. 
In Figures 4-6 we plot the same relationships over the period 1970-2000 when data for 112 
countries are available
6. Data for income per capita are from the Penn World Tables 6.2 (Heston, 
Summers et al. 2006), while data for life expectancy are from the World Development Indicators 
2007 (World Bank 2007). This dataset is similar to that used in most recent studies of the effect 
of health on economic growth. In Figure 4 we see once again a positive relationship between 
initial life expectancy (in 1970), and subsequent economic growth (over the period 1970-2000).  
In Figure 5 we see once again a negative relationship between initial life expectancy (in 1970) 
and the subsequent change in life expectancy (over the period 1970-2000). Last, Figure 6 shows 
a negative relationship during the period 1970-2000 between growth in life expectancy and 
growth in income per capita. 
 
Most of the literature on the relationship between health and growth focuses on the positive link 
between initial health and subsequent economic growth as seen in Figure 1 and Figure 4. The 
major innovation of Acemoglu and Johnson is not to instrument health in this relationship, but to 
                                                 
5 Following Acemoglu and Johnson, we use log differences as our measure of growth in life expectancy and income 
per capita. In Figures 1-6, we convert the long-term growth figures into annual growth rates by dividing the log 
difference by the number of years between the two observations. 
6 We exclude countries with HIV prevalence rates over 3% from these figures. HIV dominates the improvements 
made with respect to all other diseases in high-prevalence countries and makes the comparison of aggregate time 
trends in life expectancy rather difficult. 
 
 
7shift the emphasis to the negative relationship between growth in life expectancy and growth in 
income per capita as seen in Figure 3 and Figure 6.  
 
However, if the relationships in Figures 1 and 2 are causal, the relationship in Figure 3 becomes 
difficult to interpret. Suppose high initial life expectancy does lead to economic growth as 
suggested by Figure 1. Suppose in addition that low initial life expectancy leads to a high rate of 
growth in life expectancy as suggested by Figure 2. Combining these two mechanisms we would 
expect to see that countries with high initial life expectancy in 1940 have high rates of economic 
growth over the period 1940-2000 and relatively low rates of growth of life expectancy over the 
same period. Failing to take account of both mechanisms can yield a spurious negative 
correlation between growth in income and growth in life expectancy, even if the true relationship 
is positive.  
 
Acemoglu and Johnson continue to find a negative coefficient on growth in life expectancy in 
regressions explaining growth in income per capita even when they instrument the change in life 
expectancy with predicted mortality change. The predicted mortality variable they construct is 
the total number of deaths per 100 people living in a given country attributable to 15 diseases 
that underwent significant advances in prevention or treatment over the period.  Predicted 
mortality is the actual number of deaths prior to the health innovation, and is set to zero 
thereafter.  The countries with the largest declines in predicted mortality are therefore the 
countries with high initial mortality, which means low initial life expectancy.  
 
Figure 7 plots changes in predicted mortality, the Acemoglu and Johnson instrument, against the 
log of initial life expectancy in 1940. This graph shows that the countries that experienced the 
largest health improvements (largest reductions in predicted mortality) are those with the lowest 
initial life expectancy.  This instrument is clearly not a random assignment. Its validity depends 
on being able to exclude initial income as an explanatory variable for subsequent economic 
growth. If this exclusion is not possible, the instrument will be correlated with growth via its 
correlation with initial life expectancy as well as through its correlation with growth in life 




8An intuitive way of illustrating our point about the implausibility of the predicted mortality 
change instrument is to look at the analysis presented from a natural experiment perspective.  Let 
us define the set of 47 countries analyzed by Acemoglu and Johnson as our sample and 
hypothetically divide the sample into a treatment group and a control group. The treatment group 
gets a large shock (i.e., a relatively big increase in life expectancy), while the control group gets 
only a small shock (i.e., a relatively small increase or even a decline in life expectancy). 
Following Angrist and Pischke (2009), let us define {0,1} i D = to be the treatment indicator for 
country i,  i y Δ  to be growth in income as the outcome variable, and  0 i y Δ  to be income growth in 
the absence of the treatment. The observed difference in growth is then given by 
000 [ | 1] [ | 0] [ | 1] [ | 1] [ | 1] [ | 0] i i i i i i ii ii ii E y DE y D E y DE y DE y DE y D Δ =−Δ = = Δ =−Δ =+Δ =−Δ =
  
Observed difference  Treatment effect on the treated    Selection bias 
 
which nicely summarizes the issue at hand. The observed difference between the treatment group 
(countries with generally low life expectancy in 1940) and the control group (countries with 
generally high life expectancy in 1940) is the sum of the true treatment effect of improved health 
and the difference in growth patterns in the absence of the treatment. The observed differences 
reflect the true treatment effect if there are no differences in expected growth between the 
treatment and control group in the absence of the health shock. In the sample used in the 
Acemoglu and Johnson case, this assumption seems quite implausible; treatment is associated 
with low initial life expectancy which is correlated with low subsequent economic growth, as 
shown in Figure 1. This implies a negative selection bias. Countries in the control group share 
initial conditions associated with higher subsequent income growth. This means that countries in 
the treatment group would have done worse in terms of economic performance in the absence of 
health improvements than countries in the control group. Observing a negative growth difference 
between the treatment and control groups does thus not permit any inferences about a possible 
causal effect of health on income per capita.  
 
Table 1 shows a correlation matrix of the variables plotted in Figures 1-4.  Note that the change 
in predicted mortality is just the negative of predicted mortality in 1940, since predicted 
mortality in 2000 is uniformly set to zero. The correlation between initial life expectancy and 
 
 
9subsequent economic growth is 0.50, while the correlation between predicted mortality in 1940 
and life expectancy in 1940 is -0.70. Both correlations are significant at the 1% confidence level. 
Since initial life expectancy is not accounted for in the empirical specifications implemented by 
Acemoglu and Johnson, the instrument is correlated with an excluded variable, which will 
induce inconsistent estimates if this excluded variable is relevant for the model.   
 
 
3. Model Specification 
 
We now address the issue of the dynamics of the relationship between health and income more 
formally. The main estimates presented in Acemoglu and Johnson are built around the following 
empirical specification: 
 
  it it it i t it yx z u α πβ δ =+ + +++ ε  (1) 
 
where  it y is the outcome variable in country   at time  , i t it x  is log life expectancy,  represents 
other explanatory variables,   are country fixed effects, 
it z
i u t δ are time dummies and  it ε is an error 
term. Acemoglu and Johnson analyze log total population, log total GDP, log GDP per worker, 
and log GDP per capita as outcome variables, although the main focus of their study is on the 
effect of life expectancy on GDP per capita. We focus solely on log GDP per capita as the 
outcome. In addition, while equation (1) can be run as a panel we focus on the case where we 
analyze only two time periods, the “long difference”, with data from 1940 and 2000. There is an 
important assumption in equation (1) that health can be reduced to a single measure and can be 
measured by life expectancy, which may be disputed (Weil 2007; Bleakley 2008). 
 
One critique of Acemoglu and Johnson is that they do not control for a sufficient number of 
alternative possible explanatory variables . They do show that their results are robust to 
including average institutional quality, and initial population, interacted with a post-intervention 
dummy, but other variables could be added. In the empirical section below we investigate adding 
initial life expectancy and initial income, interacted with a post-intervention dummy, as 





10A second, though as we shall see related, critique concerns the validity of the instrument used by 
Acemoglu and Johnson. Acemoglu and Johnson argue that life expectancy in equation (1) is not 
exogenous, since income is likely to affect health, so that estimating this relationship by ordinary 
least squares (OLS) will yield biased results. They propose an instrument, predicted mortality, to 
avoid this endogeneity problem. Predicted mortality 
I
it M (mortality from diseases with a health 
innovation I in the sample period) is given by 
 
  [ ] 0 (1 )
I




=− + ∑ M  (2) 
 
where  0 di M is the mortality rate from disease  in country   at time 0, which is taken to be 1940,  
and
d i
dt I  is a dummy taking the value zero prior to technological innovation in disease  and a 
value of one after the innovation. 
d
dFt M  denotes the frontier mortality in the disease post 
intervention, taken to be zero for their baseline instrument.  In the “long difference” comparison, 
where period 0 is 1940 and period 1 is 2000, this reduces to  







I = = ∑  (3) 
 
Predicted mortality in 1940 is just the sum of observed mortality rates in the diseases under 
consideration while predicted mortality in 2000 is zero (or at the frontier if the alternative 
instrument used) since every disease considered has an innovation before 2000. The assumption 
required for this instrument to be valid is that it is uncorrelated with it ε , the error term in 
equation (1) , ) 0
I
it it ε = .  Given that the instrument is zero for all countries in 2
this reduces to the assumption that in 1940 the sum of observed mortality rates in the diseases 
under consideration is uncorrelated with the error term in 1940, th 0 0 i
; that is, Cov M 000 





  0, = ∑
 is 
.  
We derive this formally in Appendix I below.  While Acemoglu and Johnson argue that this
plausible, our view is that it is not.   
 
The problem being addressed is potential reverse causality from income to life expectancy. Such 
income effects on health seem likely since higher income can improve individual nutrition and 
access to health care as well as increase the availability of government funds for public health 
 
 
11measures, all of which are likely to reduce mortality.  For the predicted mortality instrument to 
be valid, Acemoglu and Johnson have to argue that shocks to income in 1940, while affecting 
mortality and life expectancy in 1940 overall, do not affect mortality rates in the 15 diseases they 
consider, which seems highly unlikely. We can illustrate this with the example of malaria. 
Acemoglu and Johnson date technological innovation in malaria to 1947, with the recognition by 
the Expert Committee on Malaria (1947) that DDT was an effective insecticide against 
mosquitoes. However, urbanization, vector control based on management and drainage of water 
sources, the use of insecticides, and access to quinine, had already substantially reduced the 
burden of malaria in the United States and Italy by 1947, though at a high financial cost,  while 
malaria control efforts in India were hampered by lack of funds (Snowden 2006; Packard 2007). 
Assuming that the initial burden is exogenous implies assuming that none of the factors 
explaining the relatively low death burden in Italy and the United States as compared to India in 
1940 has any explanatory power for income in 1940, which seems hard to defend.  
 
We can get a clearer picture of the likely bias introduced by this endogeneity by considering 
equation (1)  in first differences. With two time periods only and country fixed effects, it is easy 
to see that equation (1) can be rewritten as a first difference model given by: 
 




where  1 ii y yy Δ= − is the growth rate (log difference) of income per capita between period zero 
and period one (1940 and 2000),  1 iii 0 x xx Δ= − is the growth rate (log difference) of life 
expectancy, and  is the change in other explanatory variables, in country i over the 
same period. All country-specific time-invariant factors are differenced out, and the constant in 
the growth equation 
1 iii zzz Δ= −0
0 1 δ δδ =−represents the change in the time dummies. The error term in the 
growth equation is  1 iii 0 ε εε Δ= − . We can write the first difference of the predicted mortality 
instrument as  
 




0 i M MM M M
∈




12The change in predicted mortality is just the negative of the predicted mortality in 1940 since 
mortality in the diseases with new technologies is assumed to go to zero by 2000.  The regression 
(4) using the first differenced predicted mortality (5) gives numerically identical results to 
running the levels regression (1) for 1940 and 2000 with the level of predicted mortality in levels 
from equation (3) as the instrument. The problem of endogeneity of the instrument remains. In 
first differences the condition for instrument validity is  
  0, 1 0 (, ) ( )
I
ii d i i i
dD
Cov M Cov M εε
∈
ΔΔ = − − = 0 ε ∑  (6) 
 
However, if as we have argued above, mortality in the 15 diseases in 1940 is correlated with the 




Acemoglu and Johnson argue that variations in 
I
it M  are unrelated to any actions or economic 
events in the country, which makes predicted mortality a plausible exogenous instrument. We 
agree with this assessment for the dummy dt I : global technological progress in these diseases is 
plausibly uncorrelated with each country’s economic actions. However, the other component of 
the instrument is disease-specific mortality rates. Our view is that this component reflects current 
health conditions in the country, and life expectancy itself, is endogenous to current income.  
Interacting this endogenous component with the dummy for a technological innovation, or first 
differencing, does not remove the endogeneity.  
 
We could stop here and conclude that the predicted mortality instrument is unlikely to be valid, 
either in levels or in first differences. However, we can derive an equation in which predicted 
mortality is a plausibly valid instrument. We can rewrite equation (4) as  
  00 0 ( ii i t i i i i yx z u x z y 1 ) i δ πβ α πβ Δ=+ Δ+Δ+ ++ + − + ε  (7) 
 
where we have substituted for the base line income shock  0 i ε in the differenced error using 
equation (1). This formulation allows for an effect of change on life expectancy on change in 
income as in Acemoglu and Johnson. However, we also have a conditional convergence term. 
                                                 
0
7  1 ii ε ε − and  0 i ε will be uncorrelated only if  it ε is a random walk; we test and decisively reject this condition on 
the data below. 
 
 
13Countries with high life expectancy and low income in 1940, which are therefore below their 
steady-state income levels, will be expected to have faster economic growth. The advantage of 
equation (7) is that the condition for the change in predicted mortality to be a valid instrument is 
now: 




Cov M Cov M ε
∈
Δ= − 1 0 ε = ∑  (8) 
This seems reasonable. All we require is that mortality rates in the 15 diseases in 1940 are 
uncorrelated with the shock to income in 2000.  While income shocks are likely to be correlated 
over time it seems plausible that any correlation will have disappeared over a 60-year period.  
The advantage of equation (7) is that in this formulation the predicted mortality change is a valid 
instrument. This equation makes explicit the point that the equation estimated by Acemoglu and 
Johnson, equivalent to equation (7) but without the term in brackets, suffers from omitted 
variable bias, and it is the correlation with these omitted variables that is likely to make their 
instrument invalid.   
 
Given the 60-year gap between 1940 and 2000, the assumption that the error terms in levels are 
uncorrelated is plausible; any disequilibrium in 1940 should have worked itself out by 2000.  
However it is desirable to test this assumption. Bloom, Canning, and Sevilla  (2004) examine a 
model where the error term is autocorrelated over time and has the structure  
  ,1 (1 ) it i t it ε λε υ − = −+  (9) 
where  it υ  is are  independent identically distributed shocks, uncorrelated with  ,1 it ε − . This implies 
that in the growth equation the residual is given by  
  ,1 it i t it ε λε υ − Δ= − + (10) 
And we can derive the growth model between two periods, 0 and 1, from equation (1) as 
 
  000 0 ( ii i t i i i i yx z u x z y 1 ) i δ πβλδ πβ Δ=+ Δ+Δ+ + + + − + υ  (11) 
 
by replacing the lagged error term with the disequilibrium in the previous period. Note that in 
this case not all of the disequilibrium in one period is undone in the next period. Instead we have 
an error correction framework where income adjusts slowly to any disequilibrium between 
income and its steady-state level given initial health. While the residuals  it ε are correlated over 
 
 
14time, the shock  it υ is uncorrelated with any variables measured at time t-1, and these beginning-
of-period variables, such as the predicted mortality change that depends only on mortality in the 
initial period, can be used as exogenous variables or instruments when estimating equation (11). 
 
The model (11) is an encompassing model. It contains as a special case the models with 
uncorrelated errors in the level equation (1), which corresponds to  1 λ = , giving equation (7). It 
also contains as a special case the model where the errors in the level relationship are a random 
walk, which corresponds to  0 λ = in equation (9). In this case the model reduces to the regression 
estimated by Acemoglu and Johnson since, the initial levels of health and income do not affect 
economic growth.  
 
Over short time intervals we expect λ to be small, but over long time intervals λ will approach 1 
as all of the initial disequilibrium is corrected.  Cate (2004) provides a detailed discussion of the 
relationship between an underlying continuous time error correction mechanism and the value of 
λ when the process is measured at different discrete time intervals.   
  
4. Regression Results 
 
Table 2 reports regression results using the 47 country Acemoglu and Johnson data. For every set 
of results, the dependent variable is growth in per capita income during 1940-2000. In column 1 
of Table 2 we replicate the Acemoglu and Johnson results from a regression of growth in income 
per capita on the change in log life expectancy. The point estimate of -1.142 (statistically 
significant) implies that a 10% increase in life expectancy leads to an 11.4% decrease in GDP 
per capita. In column 2 of Table 2 we follow Acemoglu and Johnson and instrument the change 
in log life expectancy with predicted mortality change. We find exactly the same result as 
Acemoglu and Johnson:  the effect of growth in life expectancy on income growth is negative (a 
coefficient of -1.51), and statistically significant. With only two time periods the Acemoglu and 
Johnson fixed effects model in levels is equivalent to our first differenced model.  
 
We begin by investigating the issue of omitted variable bias and test the robustness of the model 
to the inclusion of other possible explanatory variables. A key issue is whether initial health, as 
 
 
15measured by initial life expectancy, should be included in the growth model, as suggested by 
Figure 1.  In column 3 of Table 2, we report the results of using OLS to estimate the parameters 
of a growth model that is augmented to include initial log life expectancy
8. The inclusion of 
initial life expectancy reverses the result found in column 1: both initial log life expectancy and 
the change in log life expectancy are estimated to have positive and significant effects on 
economic growth.  This means that the economies that grew fastest during 1940-2000 are those 
that had the highest life expectancies in 1940 and those that saw the fastest growth in life 
expectancy during 1940-2000.  
 
We repeat the regression in column 3 but instrument growth in life expectancy with predicted 
mortality change and report the results in column 4 of Table 2. None of the resulting coefficient 
estimates are statistically significant. The problem with this specification is that once we 
condition on initial life expectancy, the instrument completely loses predictive power for 
changes in life expectancy in the first-stage regression.  The Cragg-Donald F-Statistic of 0.137 
implies that predicted mortality has virtually zero predictive power on subsequent changes in life 
expectancy when we control for initial life expectancy. Predicted mortality in 1940 is highly 
correlated with life expectancy in 1940 and once we condition on initial life expectancy the 
instrument becomes extremely weak. 
 
In column 5 we add initial log income per capita to the model to estimate a more standard 
conditional convergence model. The addition of initial income has little impact on the OLS 
results. While we find a negative coefficient on initial GDP as is usual in conditional 
convergence models, the inclusion of initial GDP increases the estimated effect of both initial 
health and health improvements on economic growth. The fastest growing countries during 
1940-2000 are those with low initial income, high initial life expectancy, and large increases in 
life expectancy during 1940-2000. We also try to estimate the parameters of this model using 
change in predicted mortality as an instrument for the improvement in life expectancy; the results 
are reported in column 6 of Table 2. Once again, the instrument is too weak in the first stage to 
allow for a proper identification of the model.   
                                                 
8 This is equivalent to adding initial life expectancy interacted with a year dummy as an explanatory variable in the 
levels equation (1). This interaction is the same as carried out by Acemoglu and Johnson when they consider the 




One could argue that the instrument is invalid in column 3 because it is correlated with an 
relevant omitted variable, initial log life expectancy. By this logic, the instrument is valid in 
columns 4 and 6 since we control for initial health. However the instrument is now too weak to 
identify the effect of growth in life expectancy since it is highly correlated with initial life 
expectancy. These results imply that the Acemoglu and Johnson result is not robust to the 
inclusion of additional explanatory variables that are plausibly related to economic growth. With 
the addition of initial health as an explanatory variable in the growth regression the predicted 
mortality instrument is too weak to give meaningful results.  
 
An alternative, however, is to estimate the parameters of the relationship set out in equation (11). 
This contains initial income per capita as well as initial log life expectancy and the growth in life 
expectancy as explanatory factors for the growth in income per capita. However, this model also 
has a parameter restriction not employed in the estimates reported in columns (5) and (6) of 
Table 2. The coefficients on the growth in life expectancy and initial log life expectancy, in the 
error correction component, are the same.  This parameter restriction aids identification of the 
model. 
 
Table 3 reports nonlinear least squares estimates of the parameters of equation (11) on the same 
data as used in Table 2 to explain growth in income per capita during 1940-2000. The effect, π , 
of initial life expectancy and the growth in life expectancy on economic growth are the same. We 
estimate a large effect of health on economic growth.  In column 1 of Table 3 we estimate the 
relationship with non-linear least squares. We find a value of λ that is not significantly different 
from unity, indicating that all of the disequilibrium in 1940 between income and health appears 
to be corrected by the year 2000 through adjustments in income. This means that the income 
shock in 1940 and the shock in 2000 appear to be uncorrelated. In addition, the coefficient λ  
appears to be significantly different from zero, which is the condition Acemoglu and Johnson 
require for their approach to be valid (so that initial health and income can be excluded from the 
growth regression). We find that the coefficient on health (the common coefficient on initial 
health and the change in health) is positive, indicating a positive correlation between health and 




The main concern here, however, is that the change in log life expectancy  i x Δ  in equation (11) is 
endogenous to the growth in income. In column 2 of Table 3 we therefore instrument the change 
in log life expectancy with the predicted change in mortality. Note that this is now a plausibly 
valid instrument because the shock to the growth equation (11) depends only on the income 
shock in 2000, while the change in predicted mortality depends only on disease specific 
mortality measured in 1940. Using this instrument we again find positive and significant effects 
of health on growth. In columns 4 and 6 of Table 2 we estimate the effects of initial health and 
the change in health during 1940-2000 separately and the instrument is very weak. In column 2 
of Table 3 identification essentially comes from the equality of the parameters on initial health 
and the growth in health in equation (11).  
 
In the regression in column 2 of Table 3 we treat initial life expectancy and initial income per 
capita in 1940 as exogenous, which means that they are assumed to be uncorrelated with the 
income shock  1 i υ  in 2000.  Rather than using predicted mortality change as our instrument for 
change in life expectancy we can simply use initial life expectancy as the instrument. While 
initial life expectancy is in the regression already, this instrument leads to identification because 
of the parameter restriction in equation (11). The results from using initial life expectancy as the 
instrument, reported in column 3 of Table 3, are very similar to those found by using predicted 
mortality change. In addition to the change in life expectancy being endogenous, we can also 
consider initial life expectancy as endogenous and instrument both with the change in predicted 
mortality.  This corresponds to the argument that both initial life expectancy and the growth in 
life expectancy are potentially endogenous, but the change in predicted mortality is a valid 
instrument.   The results of this regression are reported in column 4 of Table 3, and as before, the 
effect of health on income is positive and significant. 
 
The results in Table 3 suggest that the coefficient λ  on the error correction component of growth 
is unity. This means that the error terms in levels in equation (1) for 1940 and 2000 appear to be 
uncorrelated. In each regression in Table 3 we find a coefficient that is not significantly different 
from one.  In Table 4 we repeat the regressions in Table 3 but impose the condition that  1 λ = . 
The resulting estimated parameter for the effect of health on income is positive and significant in 
 
 
18each specification. Column 4 of Table 4 corresponds most closely to Acemoglu and Johnson’s 
original approach. We substitute out the 1940 income shock to give equation (7), where we argue 
the predicted mortality change instrument becomes valid. We then instrument both initial log life 
expectancy and the change in log life expectancy with the predicted mortality instrument. The 
result is a large, significant, positive coefficient for the effect of life expectancy on income.   
 
The estimate of the health effect is very sensitive to the extent of error correction. For low values 
of  λ  there is little effect of initial health on economic growth. In this case the negative 
relationship between the growth in life expectancy and the growth in income per capita, shown in 
Figure 2, dominates the estimate, and health improvements appear to lower income per capita.  
For large values of λ  initial health has a greater impact on income growth, and the positive 
association between initial health and subsequent economic growth, shown in figure one, 
dominates the estimate and health improvements appear to raise income per capita. The critical 
value for λ  is around 0.75, with larger values being required to generate positive effects of 
health improvements on income.  We estimate a value of λ  close to one, but the sensitivity of 
the estimated health coefficient to the value of λ  should give us some pause. The fundamental 
reason for this sensitivity is the high degree of co-linearity between initial life expectancy, and 
the growth in life expectancy, shown in figure 2. It is intrinsically difficult to estimate separately 
the effects of the initial level, and the growth rate, of life expectancy using this data.   
 
The results in Tables 2-4 require a large number of assumptions and are sensitive to the 
specification used; we do not regard them as definitive. Our goal is only to put the Acemoglu and 
Johnson results in context, and show they can be reversed in a more general model. Further 
generalizations are possible. A richer error structure than the simple autoregressive process set 
out in equation (9) would lead to a more complex model. In estimating equation (11) we neglect 
the fixed effects and the effect of other explanatory variables. It is difficult to include these fixed 
effects explicitly. In the long difference model we have only one observation in first differences. 
In a panel data setting with shorter time intervals and more observations we have dynamic panel 
with a lagged endogenous variable, leading to well-known difficulties (Nickell 1981; Arellano 
 
 
19and Bond 1991; Blundell and Bond 1998)
9.  Bloom, Canning, and Sevilla (2004) estimate the 
model set out in equation (11) in a panel of countries using a set of factors that are fixed within 
countries over time, such a geography and climate, to capture country-specific effects, and 
include other time-varying factors that may affect income per capita, such as capital 
accumulation.  They continue to find a positive effect of health on economic growth, suggesting 




The Acemoglu and Johnson (2007) results are striking. The idea that health improvements 
actually reduce income per capita is counterintuitive and, if true, of great practical importance 
with respect to the allocation of resources to the promotion and protection of population health. 
We argue here that the Acemoglu and Johnson result hinges critically on a specification in which 
economic growth depends on contemporaneous health improvements only, so that lagged health 
has no effect. There are strong reasons to expect that the response of income to health 
improvements is not instantaneous, and that there is a lagged effect. Allowing for this lagged 
effect produces positive estimates for the effects of both lagged health and of improvements in 
health on the growth of income per capita, and thus reverses the results found by Acemoglu and 
Johnson. 
 
While we find positive results, we are left with a situation in which we are not yet able to make 
definitive inferences about the effect of population health on economic growth. There is a strong 
positive correlation between a country’s initial life expectancy and its subsequent economic 
growth, but it is difficult to offer compelling evidence that the effect is causal. We still lack a 
randomized intervention, or an indisputably compelling instrument, for initial health at the 
macroeconomic level that would allow us to identify this effect of initial life expectancy as 
causal and not the result of omitted variable bias.   
 
                                                 
9 Method of moments give asymptotically unbiased estimators in this setting but we found that a Monte Carlo study 
using generated data gave very unreliable results.  
 
 
20While we disagree with the results found by Acemoglu and Johnson we think their paper has 
identified three crucial issues that are not yet resolved. The first issue is the endogenity of health 
and the need for modeling that allows causal inference. The second issue is timing. Any effect of 
health improvements that increases income levels clearly takes some time - with slow 
convergence to a steady state, rather than a contemporaneous jump, the best we can hope for.  
The third is the indirect effect of health on population size, and the resulting pressure on scarce 
resources and income levels. Previous studies may have erred in controlling for population 
effects rather than treating these as endogenous. 
 
We have focused on the overall effect of health on income, which includes labor productivity 
and savings, as well as population effects. We agree that the population mechanism may lead to a 
negative effect of health on income in the short run, particularly since the labor productivity 
effects of early childhood health may take years to realize. However, in the longer run, 
improvements in mortality tend to lead to reduced fertility. A central question is whether induced 
reductions in fertility are sufficient to offset the population increase due to lower mortality, and 




21TABLE 1:  CORRELATION MATRIX ACEMOGLU AND JOHNSON SAMPLE OF 47 COUNTRIES  
 
Growth in 
income per capita 
1940-2000 












Growth in income per 
capita 1940-2000  1        
Growth in life expectancy 
1940-2000  -0.44***          1       
Log life expectancy 1940  0.50***  -0.97***       1     
Log GDP per capita 1940            0.13    -0.76***  0.81***  1   
Predicted mortality 1940           -0.34**  0.69***  -0.70***  -0.63***  1 
NOTE.─Table 1 shows pairwise correlation coefficients for the variables listed. *** p<0.01, ** p<0.05, * p<0.10. Based on the 





TABLE  2:  GROWTH IN LIFE  EXPECTANCY AND INCOME PER CAPITA,  ADDING  INITIAL 
CONDITIONS  
 
 G ROWTH IN INCOME PER CAPITA, 1940-2000 
           
  (1)  (2)  (3)  (4) (5) (6) 
Estimator OLS  IV  OLS  IV  OLS  IV 
           














  (0.27)  (0.40)  (1.29)  (81.3) (1.18) (66.8) 
Log life expectancy 1940      3.769***  -15.23  6.848***  -15.18 
      (0.94)  (61.4) (1.00) (54.3) 
Log GDP per capita 1940          -0.689***  0.0146 
         (0.11)  (1.81) 
           
Observations  47  47  47  47 47 47 
R-squared 0.19  0.17  0.32  -3.13  0.60  -3.09 
Cragg-Donald  F-Statistic    60.84    0.136  0.211 
Critical value for F-statistic    16.38    16.38    16.38 
NOTE.─Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1. In IV estimates change in log life expectancy is 




23TABLE 3: GROWTH IN LIFE EXPECTANCY AND INCOME PER CAPITA, ERROR CORRECTION 
MODEL  
          
  GROWTH IN INCOME PER CAPITA, 1940-2000 
          
   (1)  (2)  (3)  (4) 
Estimator   NLS  IV IV IV 
          
Intercept  α   -33.39**      
(3.385) 
-53.10**     
(13.31) 
-55.86*      
(15.08) 
-41.91**      
(10.71) 
Effect of health on 
income 
π   9.143**       
(1.067) 
14.96**       
(3.943) 
15.78**       
(4.490) 
11.24**      
(3.353) 
Convergence term  λ   1.115**       
(0.071) 
0.959**       
(0.065) 
0.947**       
(0.065) 
1.076**       
(0.135) 
R
2  0.560 0.494 0.473 0.584 
          
Endogenous      Growth in life 
expectancy 
Growth in life 
expectancy 
Growth in life 
expectancy, 
Initial log life 
expectancy 
Instrument    Change  in 
predicted 
mortality 





NOTE.─Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1. Based on the Acemoglu and Johnson 






24TABLE 4: GROWTH IN LIFE EXPECTANCY AND INCOME PER CAPITA, ERROR CORRECTION 
MODEL 
          
  GROWTH IN INCOME PER CAPITA, 1940-2000 
          
   (1)  (2)  (3)  (4) 
Estimator   NLS  IV IV IV 
          
Intercept  α   -39.37**      
(2.951)       
-46.01**      
(4.395)       
-46.21**      
4.39532        
-51.37**      
5.81075       
Effect of Health on 
Income 
π   11.28**       
(0.685)       
12.83**       
(1.018)       
12.87**       
(1.018)        
14.08**       
(1.348)       
Convergence term  λ   1 1 1 1 
R





          
Endogenous      Growth in life 
expectancy 
Growth in life 
expectancy 
Growth in life 
expectancy, 
Initial log life 
expectancy 
Instrument    Change  in 
predicted 
mortality 





NOTE.─ Robust standard errors in parentheses. *** p<0.01, ** p<0.05, * p<0.1. Based on the Acemoglu and Johnson 








































































FIG. 1.─ Life expectancy 1940 and average annual growth in income per capita 1940-2000 in the Acemoglu and 






































































FIG. 2.─ Average annual growth in life expectancy 1940-2000 and life expectancy 1940 in the Acemoglu and 
Johnson baseline sample of 47 countries.
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FIG. 3.─ Average annual growth in life expectancy and GDP per capita 1940-2000 in the Acemoglu and Johnson 
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FIG. 7.─ Absolute change in predicted mortality 1940-2000 and log life expectancy 1940 in the Acemoglu and 












35 40 45 50 55 60 65 70 75























































FIG. 4.─ Life expectancy 1970 and average annual growth in income per capita 1970-2000 in the extended sample 
of 112 countries. Source: GDP per capita: Penn World Tables 6.2; life expectancy: WDI 2007. 
 
 





































































FIG. 5.─ Average annual growth in life expectancy 1970-2000 and life expectancy 1970 in the extended sample of 
112 countries. Source: GDP per capita: Penn World Tables 6.2; life expectancy: WDI 2007.
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FIG. 6.─ Average annual growth in life expectancy and GDP per capita 1970-2000 in the extended sample of 112 
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By definition,  
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Since we have only two periods, we can express the covariance term as 
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since by construction predicted mortality at time 1 is zero so  1
I
i M = 0.  Hence, given that some 
observations in the dataset are at time zero (so that  (0 Pt ) = >0), we have 
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